Medical Care

Global TCR-T Cellular Immunotherapy Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for TCR-T Cellular Immunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding TCR-T Cellular Immunotherapy.
The TCR-T Cellular Immunotherapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global TCR-T Cellular Immunotherapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the TCR-T Cellular Immunotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BioNTech
Adaptimmune
Immunocore
Medigene AG
bluebird bio
TCR2 Therapeutics
Immatics
TScan Therapeutics
3T Biosciences
Adaptive Biotechnologies
Kite Pharma
RootPath
Eureka Therapeutics
Lion TCR
Guangzhou Xiangxue Pharmaceutical
Fosun Kite Biotechnology
Shanghai JW Therapeutics
Shanghai Heng Rui Yuan Zheng Biotechnology
Shenzhen Innovation Immunotechnology
Suzhou Neowise Biotechnology
Shenzhen BinDeBio Technology
Beijing CorreGene Biotechnology
TCRCure Biopharma Technology
BriSTAR Immunotech
Shanghai iCell Biotechnology
Segment by Type
Autologous
Allogeneic
Segment by Application
Cervical Cancer
Colorectal Cancer
Esophageal Cancer
Pancreatic Cancer
Lung Cancer
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of TCR-T Cellular Immunotherapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global TCR-T Cellular Immunotherapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Autologous
1.2.3 Allogeneic
1.3 Market by Application
1.3.1 Global TCR-T Cellular Immunotherapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cervical Cancer
1.3.3 Colorectal Cancer
1.3.4 Esophageal Cancer
1.3.5 Pancreatic Cancer
1.3.6 Lung Cancer
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global TCR-T Cellular Immunotherapy Market Perspective (2020-2031)
2.2 Global TCR-T Cellular Immunotherapy Growth Trends by Region
2.2.1 Global TCR-T Cellular Immunotherapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 TCR-T Cellular Immunotherapy Historic Market Size by Region (2020-2025)
2.2.3 TCR-T Cellular Immunotherapy Forecasted Market Size by Region (2026-2031)
2.3 TCR-T Cellular Immunotherapy Market Dynamics
2.3.1 TCR-T Cellular Immunotherapy Industry Trends
2.3.2 TCR-T Cellular Immunotherapy Market Drivers
2.3.3 TCR-T Cellular Immunotherapy Market Challenges
2.3.4 TCR-T Cellular Immunotherapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top TCR-T Cellular Immunotherapy Players by Revenue
3.1.1 Global Top TCR-T Cellular Immunotherapy Players by Revenue (2020-2025)
3.1.2 Global TCR-T Cellular Immunotherapy Revenue Market Share by Players (2020-2025)
3.2 Global TCR-T Cellular Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by TCR-T Cellular Immunotherapy Revenue
3.4 Global TCR-T Cellular Immunotherapy Market Concentration Ratio
3.4.1 Global TCR-T Cellular Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by TCR-T Cellular Immunotherapy Revenue in 2024
3.5 Global Key Players of TCR-T Cellular Immunotherapy Head office and Area Served
3.6 Global Key Players of TCR-T Cellular Immunotherapy, Product and Application
3.7 Global Key Players of TCR-T Cellular Immunotherapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 TCR-T Cellular Immunotherapy Breakdown Data by Type
4.1 Global TCR-T Cellular Immunotherapy Historic Market Size by Type (2020-2025)
4.2 Global TCR-T Cellular Immunotherapy Forecasted Market Size by Type (2026-2031)
5 TCR-T Cellular Immunotherapy Breakdown Data by Application
5.1 Global TCR-T Cellular Immunotherapy Historic Market Size by Application (2020-2025)
5.2 Global TCR-T Cellular Immunotherapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America TCR-T Cellular Immunotherapy Market Size (2020-2031)
6.2 North America TCR-T Cellular Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America TCR-T Cellular Immunotherapy Market Size by Country (2020-2025)
6.4 North America TCR-T Cellular Immunotherapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe TCR-T Cellular Immunotherapy Market Size (2020-2031)
7.2 Europe TCR-T Cellular Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe TCR-T Cellular Immunotherapy Market Size by Country (2020-2025)
7.4 Europe TCR-T Cellular Immunotherapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific TCR-T Cellular Immunotherapy Market Size (2020-2031)
8.2 Asia-Pacific TCR-T Cellular Immunotherapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific TCR-T Cellular Immunotherapy Market Size by Region (2020-2025)
8.4 Asia-Pacific TCR-T Cellular Immunotherapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America TCR-T Cellular Immunotherapy Market Size (2020-2031)
9.2 Latin America TCR-T Cellular Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America TCR-T Cellular Immunotherapy Market Size by Country (2020-2025)
9.4 Latin America TCR-T Cellular Immunotherapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa TCR-T Cellular Immunotherapy Market Size (2020-2031)
10.2 Middle East & Africa TCR-T Cellular Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa TCR-T Cellular Immunotherapy Market Size by Country (2020-2025)
10.4 Middle East & Africa TCR-T Cellular Immunotherapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BioNTech
11.1.1 BioNTech Company Details
11.1.2 BioNTech Business Overview
11.1.3 BioNTech TCR-T Cellular Immunotherapy Introduction
11.1.4 BioNTech Revenue in TCR-T Cellular Immunotherapy Business (2020-2025)
11.1.5 BioNTech Recent Development
11.2 Adaptimmune
11.2.1 Adaptimmune Company Details
11.2.2 Adaptimmune Business Overview
11.2.3 Adaptimmune TCR-T Cellular Immunotherapy Introduction
11.2.4 Adaptimmune Revenue in TCR-T Cellular Immunotherapy Business (2020-2025)
11.2.5 Adaptimmune Recent Development
11.3 Immunocore
11.3.1 Immunocore Company Details
11.3.2 Immunocore Business Overview
11.3.3 Immunocore TCR-T Cellular Immunotherapy Introduction
11.3.4 Immunocore Revenue in TCR-T Cellular Immunotherapy Business (2020-2025)
11.3.5 Immunocore Recent Development
11.4 Medigene AG
11.4.1 Medigene AG Company Details
11.4.2 Medigene AG Business Overview
11.4.3 Medigene AG TCR-T Cellular Immunotherapy Introduction
11.4.4 Medigene AG Revenue in TCR-T Cellular Immunotherapy Business (2020-2025)
11.4.5 Medigene AG Recent Development
11.5 bluebird bio
11.5.1 bluebird bio Company Details
11.5.2 bluebird bio Business Overview
11.5.3 bluebird bio TCR-T Cellular Immunotherapy Introduction
11.5.4 bluebird bio Revenue in TCR-T Cellular Immunotherapy Business (2020-2025)
11.5.5 bluebird bio Recent Development
11.6 TCR2 Therapeutics
11.6.1 TCR2 Therapeutics Company Details
11.6.2 TCR2 Therapeutics Business Overview
11.6.3 TCR2 Therapeutics TCR-T Cellular Immunotherapy Introduction
11.6.4 TCR2 Therapeutics Revenue in TCR-T Cellular Immunotherapy Business (2020-2025)
11.6.5 TCR2 Therapeutics Recent Development
11.7 Immatics
11.7.1 Immatics Company Details
11.7.2 Immatics Business Overview
11.7.3 Immatics TCR-T Cellular Immunotherapy Introduction
11.7.4 Immatics Revenue in TCR-T Cellular Immunotherapy Business (2020-2025)
11.7.5 Immatics Recent Development
11.8 TScan Therapeutics
11.8.1 TScan Therapeutics Company Details
11.8.2 TScan Therapeutics Business Overview
11.8.3 TScan Therapeutics TCR-T Cellular Immunotherapy Introduction
11.8.4 TScan Therapeutics Revenue in TCR-T Cellular Immunotherapy Business (2020-2025)
11.8.5 TScan Therapeutics Recent Development
11.9 3T Biosciences
11.9.1 3T Biosciences Company Details
11.9.2 3T Biosciences Business Overview
11.9.3 3T Biosciences TCR-T Cellular Immunotherapy Introduction
11.9.4 3T Biosciences Revenue in TCR-T Cellular Immunotherapy Business (2020-2025)
11.9.5 3T Biosciences Recent Development
11.10 Adaptive Biotechnologies
11.10.1 Adaptive Biotechnologies Company Details
11.10.2 Adaptive Biotechnologies Business Overview
11.10.3 Adaptive Biotechnologies TCR-T Cellular Immunotherapy Introduction
11.10.4 Adaptive Biotechnologies Revenue in TCR-T Cellular Immunotherapy Business (2020-2025)
11.10.5 Adaptive Biotechnologies Recent Development
11.11 Kite Pharma
11.11.1 Kite Pharma Company Details
11.11.2 Kite Pharma Business Overview
11.11.3 Kite Pharma TCR-T Cellular Immunotherapy Introduction
11.11.4 Kite Pharma Revenue in TCR-T Cellular Immunotherapy Business (2020-2025)
11.11.5 Kite Pharma Recent Development
11.12 RootPath
11.12.1 RootPath Company Details
11.12.2 RootPath Business Overview
11.12.3 RootPath TCR-T Cellular Immunotherapy Introduction
11.12.4 RootPath Revenue in TCR-T Cellular Immunotherapy Business (2020-2025)
11.12.5 RootPath Recent Development
11.13 Eureka Therapeutics
11.13.1 Eureka Therapeutics Company Details
11.13.2 Eureka Therapeutics Business Overview
11.13.3 Eureka Therapeutics TCR-T Cellular Immunotherapy Introduction
11.13.4 Eureka Therapeutics Revenue in TCR-T Cellular Immunotherapy Business (2020-2025)
11.13.5 Eureka Therapeutics Recent Development
11.14 Lion TCR
11.14.1 Lion TCR Company Details
11.14.2 Lion TCR Business Overview
11.14.3 Lion TCR TCR-T Cellular Immunotherapy Introduction
11.14.4 Lion TCR Revenue in TCR-T Cellular Immunotherapy Business (2020-2025)
11.14.5 Lion TCR Recent Development
11.15 Guangzhou Xiangxue Pharmaceutical
11.15.1 Guangzhou Xiangxue Pharmaceutical Company Details
11.15.2 Guangzhou Xiangxue Pharmaceutical Business Overview
11.15.3 Guangzhou Xiangxue Pharmaceutical TCR-T Cellular Immunotherapy Introduction
11.15.4 Guangzhou Xiangxue Pharmaceutical Revenue in TCR-T Cellular Immunotherapy Business (2020-2025)
11.15.5 Guangzhou Xiangxue Pharmaceutical Recent Development
11.16 Fosun Kite Biotechnology
11.16.1 Fosun Kite Biotechnology Company Details
11.16.2 Fosun Kite Biotechnology Business Overview
11.16.3 Fosun Kite Biotechnology TCR-T Cellular Immunotherapy Introduction
11.16.4 Fosun Kite Biotechnology Revenue in TCR-T Cellular Immunotherapy Business (2020-2025)
11.16.5 Fosun Kite Biotechnology Recent Development
11.17 Shanghai JW Therapeutics
11.17.1 Shanghai JW Therapeutics Company Details
11.17.2 Shanghai JW Therapeutics Business Overview
11.17.3 Shanghai JW Therapeutics TCR-T Cellular Immunotherapy Introduction
11.17.4 Shanghai JW Therapeutics Revenue in TCR-T Cellular Immunotherapy Business (2020-2025)
11.17.5 Shanghai JW Therapeutics Recent Development
11.18 Shanghai Heng Rui Yuan Zheng Biotechnology
11.18.1 Shanghai Heng Rui Yuan Zheng Biotechnology Company Details
11.18.2 Shanghai Heng Rui Yuan Zheng Biotechnology Business Overview
11.18.3 Shanghai Heng Rui Yuan Zheng Biotechnology TCR-T Cellular Immunotherapy Introduction
11.18.4 Shanghai Heng Rui Yuan Zheng Biotechnology Revenue in TCR-T Cellular Immunotherapy Business (2020-2025)
11.18.5 Shanghai Heng Rui Yuan Zheng Biotechnology Recent Development
11.19 Shenzhen Innovation Immunotechnology
11.19.1 Shenzhen Innovation Immunotechnology Company Details
11.19.2 Shenzhen Innovation Immunotechnology Business Overview
11.19.3 Shenzhen Innovation Immunotechnology TCR-T Cellular Immunotherapy Introduction
11.19.4 Shenzhen Innovation Immunotechnology Revenue in TCR-T Cellular Immunotherapy Business (2020-2025)
11.19.5 Shenzhen Innovation Immunotechnology Recent Development
11.20 Suzhou Neowise Biotechnology
11.20.1 Suzhou Neowise Biotechnology Company Details
11.20.2 Suzhou Neowise Biotechnology Business Overview
11.20.3 Suzhou Neowise Biotechnology TCR-T Cellular Immunotherapy Introduction
11.20.4 Suzhou Neowise Biotechnology Revenue in TCR-T Cellular Immunotherapy Business (2020-2025)
11.20.5 Suzhou Neowise Biotechnology Recent Development
11.21 Shenzhen BinDeBio Technology
11.21.1 Shenzhen BinDeBio Technology Company Details
11.21.2 Shenzhen BinDeBio Technology Business Overview
11.21.3 Shenzhen BinDeBio Technology TCR-T Cellular Immunotherapy Introduction
11.21.4 Shenzhen BinDeBio Technology Revenue in TCR-T Cellular Immunotherapy Business (2020-2025)
11.21.5 Shenzhen BinDeBio Technology Recent Development
11.22 Beijing CorreGene Biotechnology
11.22.1 Beijing CorreGene Biotechnology Company Details
11.22.2 Beijing CorreGene Biotechnology Business Overview
11.22.3 Beijing CorreGene Biotechnology TCR-T Cellular Immunotherapy Introduction
11.22.4 Beijing CorreGene Biotechnology Revenue in TCR-T Cellular Immunotherapy Business (2020-2025)
11.22.5 Beijing CorreGene Biotechnology Recent Development
11.23 TCRCure Biopharma Technology
11.23.1 TCRCure Biopharma Technology Company Details
11.23.2 TCRCure Biopharma Technology Business Overview
11.23.3 TCRCure Biopharma Technology TCR-T Cellular Immunotherapy Introduction
11.23.4 TCRCure Biopharma Technology Revenue in TCR-T Cellular Immunotherapy Business (2020-2025)
11.23.5 TCRCure Biopharma Technology Recent Development
11.24 BriSTAR Immunotech
11.24.1 BriSTAR Immunotech Company Details
11.24.2 BriSTAR Immunotech Business Overview
11.24.3 BriSTAR Immunotech TCR-T Cellular Immunotherapy Introduction
11.24.4 BriSTAR Immunotech Revenue in TCR-T Cellular Immunotherapy Business (2020-2025)
11.24.5 BriSTAR Immunotech Recent Development
11.25 Shanghai iCell Biotechnology
11.25.1 Shanghai iCell Biotechnology Company Details
11.25.2 Shanghai iCell Biotechnology Business Overview
11.25.3 Shanghai iCell Biotechnology TCR-T Cellular Immunotherapy Introduction
11.25.4 Shanghai iCell Biotechnology Revenue in TCR-T Cellular Immunotherapy Business (2020-2025)
11.25.5 Shanghai iCell Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global TCR-T Cellular Immunotherapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Autologous
Table 3. Key Players of Allogeneic
Table 4. Global TCR-T Cellular Immunotherapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global TCR-T Cellular Immunotherapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global TCR-T Cellular Immunotherapy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global TCR-T Cellular Immunotherapy Market Share by Region (2020-2025)
Table 8. Global TCR-T Cellular Immunotherapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global TCR-T Cellular Immunotherapy Market Share by Region (2026-2031)
Table 10. TCR-T Cellular Immunotherapy Market Trends
Table 11. TCR-T Cellular Immunotherapy Market Drivers
Table 12. TCR-T Cellular Immunotherapy Market Challenges
Table 13. TCR-T Cellular Immunotherapy Market Restraints
Table 14. Global TCR-T Cellular Immunotherapy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global TCR-T Cellular Immunotherapy Market Share by Players (2020-2025)
Table 16. Global Top TCR-T Cellular Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TCR-T Cellular Immunotherapy as of 2024)
Table 17. Ranking of Global Top TCR-T Cellular Immunotherapy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by TCR-T Cellular Immunotherapy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of TCR-T Cellular Immunotherapy, Headquarters and Area Served
Table 20. Global Key Players of TCR-T Cellular Immunotherapy, Product and Application
Table 21. Global Key Players of TCR-T Cellular Immunotherapy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global TCR-T Cellular Immunotherapy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global TCR-T Cellular Immunotherapy Revenue Market Share by Type (2020-2025)
Table 25. Global TCR-T Cellular Immunotherapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global TCR-T Cellular Immunotherapy Revenue Market Share by Type (2026-2031)
Table 27. Global TCR-T Cellular Immunotherapy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global TCR-T Cellular Immunotherapy Revenue Market Share by Application (2020-2025)
Table 29. Global TCR-T Cellular Immunotherapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global TCR-T Cellular Immunotherapy Revenue Market Share by Application (2026-2031)
Table 31. North America TCR-T Cellular Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America TCR-T Cellular Immunotherapy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America TCR-T Cellular Immunotherapy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe TCR-T Cellular Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe TCR-T Cellular Immunotherapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe TCR-T Cellular Immunotherapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific TCR-T Cellular Immunotherapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific TCR-T Cellular Immunotherapy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific TCR-T Cellular Immunotherapy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America TCR-T Cellular Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America TCR-T Cellular Immunotherapy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America TCR-T Cellular Immunotherapy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa TCR-T Cellular Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa TCR-T Cellular Immunotherapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa TCR-T Cellular Immunotherapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. BioNTech Company Details
Table 47. BioNTech Business Overview
Table 48. BioNTech TCR-T Cellular Immunotherapy Product
Table 49. BioNTech Revenue in TCR-T Cellular Immunotherapy Business (2020-2025) & (US$ Million)
Table 50. BioNTech Recent Development
Table 51. Adaptimmune Company Details
Table 52. Adaptimmune Business Overview
Table 53. Adaptimmune TCR-T Cellular Immunotherapy Product
Table 54. Adaptimmune Revenue in TCR-T Cellular Immunotherapy Business (2020-2025) & (US$ Million)
Table 55. Adaptimmune Recent Development
Table 56. Immunocore Company Details
Table 57. Immunocore Business Overview
Table 58. Immunocore TCR-T Cellular Immunotherapy Product
Table 59. Immunocore Revenue in TCR-T Cellular Immunotherapy Business (2020-2025) & (US$ Million)
Table 60. Immunocore Recent Development
Table 61. Medigene AG Company Details
Table 62. Medigene AG Business Overview
Table 63. Medigene AG TCR-T Cellular Immunotherapy Product
Table 64. Medigene AG Revenue in TCR-T Cellular Immunotherapy Business (2020-2025) & (US$ Million)
Table 65. Medigene AG Recent Development
Table 66. bluebird bio Company Details
Table 67. bluebird bio Business Overview
Table 68. bluebird bio TCR-T Cellular Immunotherapy Product
Table 69. bluebird bio Revenue in TCR-T Cellular Immunotherapy Business (2020-2025) & (US$ Million)
Table 70. bluebird bio Recent Development
Table 71. TCR2 Therapeutics Company Details
Table 72. TCR2 Therapeutics Business Overview
Table 73. TCR2 Therapeutics TCR-T Cellular Immunotherapy Product
Table 74. TCR2 Therapeutics Revenue in TCR-T Cellular Immunotherapy Business (2020-2025) & (US$ Million)
Table 75. TCR2 Therapeutics Recent Development
Table 76. Immatics Company Details
Table 77. Immatics Business Overview
Table 78. Immatics TCR-T Cellular Immunotherapy Product
Table 79. Immatics Revenue in TCR-T Cellular Immunotherapy Business (2020-2025) & (US$ Million)
Table 80. Immatics Recent Development
Table 81. TScan Therapeutics Company Details
Table 82. TScan Therapeutics Business Overview
Table 83. TScan Therapeutics TCR-T Cellular Immunotherapy Product
Table 84. TScan Therapeutics Revenue in TCR-T Cellular Immunotherapy Business (2020-2025) & (US$ Million)
Table 85. TScan Therapeutics Recent Development
Table 86. 3T Biosciences Company Details
Table 87. 3T Biosciences Business Overview
Table 88. 3T Biosciences TCR-T Cellular Immunotherapy Product
Table 89. 3T Biosciences Revenue in TCR-T Cellular Immunotherapy Business (2020-2025) & (US$ Million)
Table 90. 3T Biosciences Recent Development
Table 91. Adaptive Biotechnologies Company Details
Table 92. Adaptive Biotechnologies Business Overview
Table 93. Adaptive Biotechnologies TCR-T Cellular Immunotherapy Product
Table 94. Adaptive Biotechnologies Revenue in TCR-T Cellular Immunotherapy Business (2020-2025) & (US$ Million)
Table 95. Adaptive Biotechnologies Recent Development
Table 96. Kite Pharma Company Details
Table 97. Kite Pharma Business Overview
Table 98. Kite Pharma TCR-T Cellular Immunotherapy Product
Table 99. Kite Pharma Revenue in TCR-T Cellular Immunotherapy Business (2020-2025) & (US$ Million)
Table 100. Kite Pharma Recent Development
Table 101. RootPath Company Details
Table 102. RootPath Business Overview
Table 103. RootPath TCR-T Cellular Immunotherapy Product
Table 104. RootPath Revenue in TCR-T Cellular Immunotherapy Business (2020-2025) & (US$ Million)
Table 105. RootPath Recent Development
Table 106. Eureka Therapeutics Company Details
Table 107. Eureka Therapeutics Business Overview
Table 108. Eureka Therapeutics TCR-T Cellular Immunotherapy Product
Table 109. Eureka Therapeutics Revenue in TCR-T Cellular Immunotherapy Business (2020-2025) & (US$ Million)
Table 110. Eureka Therapeutics Recent Development
Table 111. Lion TCR Company Details
Table 112. Lion TCR Business Overview
Table 113. Lion TCR TCR-T Cellular Immunotherapy Product
Table 114. Lion TCR Revenue in TCR-T Cellular Immunotherapy Business (2020-2025) & (US$ Million)
Table 115. Lion TCR Recent Development
Table 116. Guangzhou Xiangxue Pharmaceutical Company Details
Table 117. Guangzhou Xiangxue Pharmaceutical Business Overview
Table 118. Guangzhou Xiangxue Pharmaceutical TCR-T Cellular Immunotherapy Product
Table 119. Guangzhou Xiangxue Pharmaceutical Revenue in TCR-T Cellular Immunotherapy Business (2020-2025) & (US$ Million)
Table 120. Guangzhou Xiangxue Pharmaceutical Recent Development
Table 121. Fosun Kite Biotechnology Company Details
Table 122. Fosun Kite Biotechnology Business Overview
Table 123. Fosun Kite Biotechnology TCR-T Cellular Immunotherapy Product
Table 124. Fosun Kite Biotechnology Revenue in TCR-T Cellular Immunotherapy Business (2020-2025) & (US$ Million)
Table 125. Fosun Kite Biotechnology Recent Development
Table 126. Shanghai JW Therapeutics Company Details
Table 127. Shanghai JW Therapeutics Business Overview
Table 128. Shanghai JW Therapeutics TCR-T Cellular Immunotherapy Product
Table 129. Shanghai JW Therapeutics Revenue in TCR-T Cellular Immunotherapy Business (2020-2025) & (US$ Million)
Table 130. Shanghai JW Therapeutics Recent Development
Table 131. Shanghai Heng Rui Yuan Zheng Biotechnology Company Details
Table 132. Shanghai Heng Rui Yuan Zheng Biotechnology Business Overview
Table 133. Shanghai Heng Rui Yuan Zheng Biotechnology TCR-T Cellular Immunotherapy Product
Table 134. Shanghai Heng Rui Yuan Zheng Biotechnology Revenue in TCR-T Cellular Immunotherapy Business (2020-2025) & (US$ Million)
Table 135. Shanghai Heng Rui Yuan Zheng Biotechnology Recent Development
Table 136. Shenzhen Innovation Immunotechnology Company Details
Table 137. Shenzhen Innovation Immunotechnology Business Overview
Table 138. Shenzhen Innovation Immunotechnology TCR-T Cellular Immunotherapy Product
Table 139. Shenzhen Innovation Immunotechnology Revenue in TCR-T Cellular Immunotherapy Business (2020-2025) & (US$ Million)
Table 140. Shenzhen Innovation Immunotechnology Recent Development
Table 141. Suzhou Neowise Biotechnology Company Details
Table 142. Suzhou Neowise Biotechnology Business Overview
Table 143. Suzhou Neowise Biotechnology TCR-T Cellular Immunotherapy Product
Table 144. Suzhou Neowise Biotechnology Revenue in TCR-T Cellular Immunotherapy Business (2020-2025) & (US$ Million)
Table 145. Suzhou Neowise Biotechnology Recent Development
Table 146. Shenzhen BinDeBio Technology Company Details
Table 147. Shenzhen BinDeBio Technology Business Overview
Table 148. Shenzhen BinDeBio Technology TCR-T Cellular Immunotherapy Product
Table 149. Shenzhen BinDeBio Technology Revenue in TCR-T Cellular Immunotherapy Business (2020-2025) & (US$ Million)
Table 150. Shenzhen BinDeBio Technology Recent Development
Table 151. Beijing CorreGene Biotechnology Company Details
Table 152. Beijing CorreGene Biotechnology Business Overview
Table 153. Beijing CorreGene Biotechnology TCR-T Cellular Immunotherapy Product
Table 154. Beijing CorreGene Biotechnology Revenue in TCR-T Cellular Immunotherapy Business (2020-2025) & (US$ Million)
Table 155. Beijing CorreGene Biotechnology Recent Development
Table 156. TCRCure Biopharma Technology Company Details
Table 157. TCRCure Biopharma Technology Business Overview
Table 158. TCRCure Biopharma Technology TCR-T Cellular Immunotherapy Product
Table 159. TCRCure Biopharma Technology Revenue in TCR-T Cellular Immunotherapy Business (2020-2025) & (US$ Million)
Table 160. TCRCure Biopharma Technology Recent Development
Table 161. BriSTAR Immunotech Company Details
Table 162. BriSTAR Immunotech Business Overview
Table 163. BriSTAR Immunotech TCR-T Cellular Immunotherapy Product
Table 164. BriSTAR Immunotech Revenue in TCR-T Cellular Immunotherapy Business (2020-2025) & (US$ Million)
Table 165. BriSTAR Immunotech Recent Development
Table 166. Shanghai iCell Biotechnology Company Details
Table 167. Shanghai iCell Biotechnology Business Overview
Table 168. Shanghai iCell Biotechnology TCR-T Cellular Immunotherapy Product
Table 169. Shanghai iCell Biotechnology Revenue in TCR-T Cellular Immunotherapy Business (2020-2025) & (US$ Million)
Table 170. Shanghai iCell Biotechnology Recent Development
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
Table 174. Authors List of This Report


List of Figures
Figure 1. TCR-T Cellular Immunotherapy Picture
Figure 2. Global TCR-T Cellular Immunotherapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global TCR-T Cellular Immunotherapy Market Share by Type: 2024 VS 2031
Figure 4. Autologous Features
Figure 5. Allogeneic Features
Figure 6. Global TCR-T Cellular Immunotherapy Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global TCR-T Cellular Immunotherapy Market Share by Application: 2024 VS 2031
Figure 8. Cervical Cancer Case Studies
Figure 9. Colorectal Cancer Case Studies
Figure 10. Esophageal Cancer Case Studies
Figure 11. Pancreatic Cancer Case Studies
Figure 12. Lung Cancer Case Studies
Figure 13. TCR-T Cellular Immunotherapy Report Years Considered
Figure 14. Global TCR-T Cellular Immunotherapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global TCR-T Cellular Immunotherapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global TCR-T Cellular Immunotherapy Market Share by Region: 2024 VS 2031
Figure 17. Global TCR-T Cellular Immunotherapy Market Share by Players in 2024
Figure 18. Global Top TCR-T Cellular Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TCR-T Cellular Immunotherapy as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by TCR-T Cellular Immunotherapy Revenue in 2024
Figure 20. North America TCR-T Cellular Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America TCR-T Cellular Immunotherapy Market Share by Country (2020-2031)
Figure 22. United States TCR-T Cellular Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada TCR-T Cellular Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe TCR-T Cellular Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe TCR-T Cellular Immunotherapy Market Share by Country (2020-2031)
Figure 26. Germany TCR-T Cellular Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France TCR-T Cellular Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. TCR-T Cellular Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy TCR-T Cellular Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia TCR-T Cellular Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries TCR-T Cellular Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific TCR-T Cellular Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific TCR-T Cellular Immunotherapy Market Share by Region (2020-2031)
Figure 34. China TCR-T Cellular Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan TCR-T Cellular Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea TCR-T Cellular Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia TCR-T Cellular Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India TCR-T Cellular Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia TCR-T Cellular Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America TCR-T Cellular Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America TCR-T Cellular Immunotherapy Market Share by Country (2020-2031)
Figure 42. Mexico TCR-T Cellular Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil TCR-T Cellular Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa TCR-T Cellular Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa TCR-T Cellular Immunotherapy Market Share by Country (2020-2031)
Figure 46. Turkey TCR-T Cellular Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia TCR-T Cellular Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE TCR-T Cellular Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. BioNTech Revenue Growth Rate in TCR-T Cellular Immunotherapy Business (2020-2025)
Figure 50. Adaptimmune Revenue Growth Rate in TCR-T Cellular Immunotherapy Business (2020-2025)
Figure 51. Immunocore Revenue Growth Rate in TCR-T Cellular Immunotherapy Business (2020-2025)
Figure 52. Medigene AG Revenue Growth Rate in TCR-T Cellular Immunotherapy Business (2020-2025)
Figure 53. bluebird bio Revenue Growth Rate in TCR-T Cellular Immunotherapy Business (2020-2025)
Figure 54. TCR2 Therapeutics Revenue Growth Rate in TCR-T Cellular Immunotherapy Business (2020-2025)
Figure 55. Immatics Revenue Growth Rate in TCR-T Cellular Immunotherapy Business (2020-2025)
Figure 56. TScan Therapeutics Revenue Growth Rate in TCR-T Cellular Immunotherapy Business (2020-2025)
Figure 57. 3T Biosciences Revenue Growth Rate in TCR-T Cellular Immunotherapy Business (2020-2025)
Figure 58. Adaptive Biotechnologies Revenue Growth Rate in TCR-T Cellular Immunotherapy Business (2020-2025)
Figure 59. Kite Pharma Revenue Growth Rate in TCR-T Cellular Immunotherapy Business (2020-2025)
Figure 60. RootPath Revenue Growth Rate in TCR-T Cellular Immunotherapy Business (2020-2025)
Figure 61. Eureka Therapeutics Revenue Growth Rate in TCR-T Cellular Immunotherapy Business (2020-2025)
Figure 62. Lion TCR Revenue Growth Rate in TCR-T Cellular Immunotherapy Business (2020-2025)
Figure 63. Guangzhou Xiangxue Pharmaceutical Revenue Growth Rate in TCR-T Cellular Immunotherapy Business (2020-2025)
Figure 64. Fosun Kite Biotechnology Revenue Growth Rate in TCR-T Cellular Immunotherapy Business (2020-2025)
Figure 65. Shanghai JW Therapeutics Revenue Growth Rate in TCR-T Cellular Immunotherapy Business (2020-2025)
Figure 66. Shanghai Heng Rui Yuan Zheng Biotechnology Revenue Growth Rate in TCR-T Cellular Immunotherapy Business (2020-2025)
Figure 67. Shenzhen Innovation Immunotechnology Revenue Growth Rate in TCR-T Cellular Immunotherapy Business (2020-2025)
Figure 68. Suzhou Neowise Biotechnology Revenue Growth Rate in TCR-T Cellular Immunotherapy Business (2020-2025)
Figure 69. Shenzhen BinDeBio Technology Revenue Growth Rate in TCR-T Cellular Immunotherapy Business (2020-2025)
Figure 70. Beijing CorreGene Biotechnology Revenue Growth Rate in TCR-T Cellular Immunotherapy Business (2020-2025)
Figure 71. TCRCure Biopharma Technology Revenue Growth Rate in TCR-T Cellular Immunotherapy Business (2020-2025)
Figure 72. BriSTAR Immunotech Revenue Growth Rate in TCR-T Cellular Immunotherapy Business (2020-2025)
Figure 73. Shanghai iCell Biotechnology Revenue Growth Rate in TCR-T Cellular Immunotherapy Business (2020-2025)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies